Nabla Bio: Designing antibodies with atomic precision

Nabla Bio is an AI antibody drug design company with collaborations with AstraZeneca, Bristol Myers Squibb and Takeda.

For Nabla Bio we helped them develop their new brand positioning, content for their website, and communications to effectively distribute news of their Series A financing and first pharmaceutical collaborations.

Previous
Previous

Treeline: Making medicines at the highest level